Flow Cytometry Revenue and Competitors

Location

N/A

Total Funding

Analytics

Industry

Estimated Revenue & Valuation

  • Flow Cytometry's estimated annual revenue is currently $3.4M per year.(i)
  • Flow Cytometry's estimated revenue per employee is $112,000

Employee Data

  • Flow Cytometry has 30 Employees.(i)
  • Flow Cytometry grew their employee count by -21% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.5M86-10%N/AN/A
#2
$1.9M2637%$18.3MN/A
#3
$1.1M90%N/AN/A
Add Company

At Intellicyt, our mission is to enable bioscience enterprises to rapidly and cost effectively screen and profile disease- and physiologically-relevant model systems for phenotypic endpoints using cell-based and/or bead-based assays. We do this by providing easy-to-use hardware, software, and reagent systems that are optimized to conserve precious samples, use less reagent, and to minimize time-to-answer to both enhance workflow productivity and to preserve the biology of interest. All major pharmaceutical companies and many biotechnology companies and academic institutions have invested in Intellicyt solutions to give their cell-based screening campaigns the edge.

keywords:N/A

N/A

Total Funding

30

Number of Employees

$3.4M

Revenue (est)

-21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Flow Cytometry News

2022-04-20 - New BD Reagents Enable Researchers to Break Through ...

Flow cytometry is a popular technique in biomedical research that allows scientists to identify and analyze single cells based on their...

2022-04-19 - Advances in flow cytometry

This process allows cell populations to be examined and/or purified based on their fluorescent or light-scattering characteristics. Flow...

2022-04-17 - Global Flow Cytometry Market Report With Executive and ...

“Flow Cytometry Markets. Forecasts by Technology. Product and Application. With Executive and Consultant Guides and including Customized...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.5M3015%N/A
#2
N/A303%N/A
#3
$4.2M307%N/A
#4
$6.5M30-3%N/A
#5
$5.6M30-6%N/A